Pharmacology, Toxicology and Pharmaceutical Science
Acetylcholine
15%
Acetylcholinesterase
50%
Adverse Event
13%
Alzheimer's Disease
46%
Anemia
50%
Antiapoptotic
12%
Antihypertensive Agent
25%
Antiinfective Agent
8%
Antioxidant
48%
Apigenin
25%
Autism
47%
Bisabolol
50%
C Reactive Protein
16%
C57BL 6 Mouse
15%
Cardiotoxicity
25%
Cardiovascular Disease
8%
Chemotherapy
25%
Chronic Kidney Failure
25%
Chronic Obstructive Lung Disease
25%
Citronellol
25%
Cognitive Defect
40%
Cohort Study
25%
Comorbidity
33%
Compulsion
65%
Controlled Drug Release
10%
Controlled Release
25%
Creatinine
16%
Cross-Sectional Study
28%
Cytokine
22%
Diabetes Mellitus
15%
Disease
59%
Diseases
12%
Dizocilpine
25%
Dopamine Receptor Stimulating Agent
75%
Doxorubicin
50%
Drug Release
8%
Dupilumab
25%
Dyslipidemia
10%
Enteric Coating
25%
Esterase Inhibitor
50%
Excitotoxicity
8%
Ferritin
8%
Film Coating
25%
Glutamic Acid
25%
Glycogen Synthase Kinase
25%
Histamine
10%
Histamine H3 Receptor
21%
Histamine H3 Receptor Antagonist
75%
Hydration
25%
Hyperactivity
9%
Hypovitaminosis D
16%
IC50
10%
Inactivated Vaccine
25%
Infection
66%
Inflammation
52%
Intraperitoneal Injection
11%
Isotretinoin
25%
Limonene
25%
Lycopodium
25%
Malignant Neoplasm
28%
Mortality Rate
40%
Mouse
100%
Mouse Model
13%
Myrcene
25%
Nanocarrier
12%
Nanomaterial
12%
Nanomedicine
25%
Narcolepsy
9%
Nerve Degeneration
50%
Nervous System Inflammation
36%
Nicotinic Receptor
9%
Non Insulin Dependent Diabetes Mellitus
27%
Noscapine
25%
Novel Formulation
25%
Observational Study
14%
Parkinson's Disease
60%
Pharmacogenetics
8%
Pharmacogenomics
25%
Pharmacotherapy
25%
Phosphatidylinositol 3 Kinase
25%
Pilocarpine
25%
Prevalence
27%
Protein C Fos
25%
Receptor Agonist
12%
Rheumatoid Arthritis
25%
Rotenone
75%
Scanning Electron Microscopy
16%
Sesquiterpene
25%
Severe Acute Respiratory Syndrome
10%
Side Effect
10%
Sodium Valproate
50%
Symptom
28%
Synuclein
15%
Systemic Administration
17%
Tablet
25%
Tannin
25%
Terpene
28%
Theophylline
25%
Transcription Factor Nrf2
25%
Vitamin D Deficiency
16%
Keyphrases
Age-related Neurodegeneration
6%
Agonist Treatment
6%
Alzheimer's Disease
12%
American College of Cardiology
25%
Amnesia
25%
Antagonism
6%
Antihypertension
6%
Anxiety Level
6%
Binary Regression Analysis
6%
Brain Neurotransmitters
6%
C57BL
6%
Cancer Therapeutic Agents
8%
CDLQI
7%
Citronellol
25%
Cognitive Deficits
25%
Cognitive Effects
6%
Comorbid Diseases
6%
Compulsive Behavior
12%
Control Evaluation
16%
Controlled Drug Release
10%
Controlled-release Tablets
25%
COVID-19 Incidence
25%
Definitive Treatment
6%
Dependent Entries
8%
Dispensing Practice
25%
Docking Studies
6%
Drug Elimination
8%
Dupilumab
25%
E100
25%
Emergency Use Authorization
25%
Emotional Response
6%
Enteric Coating
25%
Financial Impact
12%
First Seizure
6%
Folate Levels
8%
Gastro-resistant
25%
Generic Equivalent
8%
Glycogen Synthase Kinase 3 (GSK3)
25%
H3 Receptor
6%
H3R Antagonist
18%
Heat Decomposition
8%
Hippocampus
6%
Histamine H3 Receptor
25%
Hypertension Guidelines
6%
Immune Mediators
8%
In Silico
6%
Inflammatory Factors
8%
Ischemic Region
8%
JNC 8
12%
JNC 8 Guidelines
12%
Kindling Development
8%
Local Researcher
12%
Locomotor Activity
6%
Long-term Memory
6%
LY294002
6%
Lycopodium
25%
Matrix Components
8%
Memory Deficits
6%
Memory Enhancing
6%
Memory Impairment
6%
Methylcitric Acid
12%
Methylmalonic Acid
20%
MK-801
25%
Moderate-to-severe Atopic Dermatitis
14%
Multimodal Action
6%
Neurodegenerative Diseases
12%
Neuroprotective Mechanisms
6%
Neurovascular Unit
8%
Novel Object Recognition
18%
Nrf2-mediated Antioxidant Defense
25%
Open Field Test
6%
Oxidative Glutamate Toxicity
25%
Oxidative Stress Effect
6%
Passive Mode
8%
Pentylenetetrazole Kindling
25%
Performance Improvement
6%
Pharmacological Control
6%
Phosphatidylinositol 3-kinase Inhibitor
6%
Phosphoinositide 3-kinase (PI3K)
25%
Physician Adherence
6%
Physicochemical Properties
6%
PI3K-AKT-mTOR Pathway
12%
Pilocarpine-induced Epilepsy
25%
Poloxamer 407
25%
Post-stroke Inflammation
8%
Proinflammatory Stress
6%
Pruritus NRS
7%
Reducing Treatment
8%
Resident Cells
8%
SCORing Atopic Dermatitis (SCORAD)
7%
Severe COVID-19 Outcomes
25%
Signaling Activation
25%
Signaling Pathway
25%
Smart Chemotherapy
25%
Spontaneous Locomotor Activity
6%
Stress Cascade
25%
Systemic Administration
12%
Valeric Acid
25%
Vitamin B12 Deficiency
25%
α-synuclein Aggregation
6%
Neuroscience
Age-Related Neurodegenerative Disorder
6%
Alzheimer's Disease
8%
Apigenin
25%
Autophagy
25%
Behavior (Neuroscience)
6%
Cognitive Disorders
25%
Compulsive Behavior
25%
Cyanocobalamin
25%
Dementia Praecox
8%
Dopaminergic Neuron
25%
Folate
5%
Folic Acid
11%
H3 Receptor Antagonist
25%
Heteroreceptor
5%
High-Mobility Group
12%
Hippo Signaling Pathway
25%
Histamine
16%
Homocysteine
13%
Inverse Agonist
25%
Kindling
25%
Limonene
25%
LY294002
12%
Lysosome
7%
Myrcene
25%
Neurodegenerative Disorder
7%
Neuroprotective Agent
7%
Nicotinic Acetylcholine Receptor
9%
Noscapine
25%
Oxidative Stress
50%
Parkinson's Disease
11%
Pervasive Developmental Disorder
11%
Phosphoinositide 3-Kinase Inhibitor
12%
Pilocarpine
25%
Protein C Fos
25%
Rotenone
25%
Sodium Valproate
25%
Status Epilepticus
25%
Substantia Nigra Pars Compacta
7%
Synuclein
7%